Abstract
Thiazolidinediones (TZDs) are a class of drugs used for treatment of type 2 diabetes, but also can exert pleiotropic effects, including anti-inflammatory and vascular protective effects. However, important side-effects such as significant weight gain, increased adiposity, peripheral edema, increased rate of bone fracture and augmented risk of congestive heart failure are associated to TZD…